Abstract-Hyperaldosteronism is associated with hypertension, cardiovascular fibrosis, and electrolyte disturbances, including hypomagnesemia. Mechanisms underlying aldosterone-mediated Mg 2ϩ changes are unclear, but the novel Mg 2ϩ transporters TRPM6 and TRPM7 may be important. We examined whether aldosterone influences renal TRPM6/7 and the TRPM7 downstream target annexin-1 and tested the hypothesis that Mg 2ϩ administration ameliorates aldosterone-induced cardiovascular and renal injury and prevents aldosterone-associated hypertension. C57B6 mice were studied (12 weeks, nϭ8 to 9/group); (1) control group (0.2% dietary Mg 2ϩ ), (2) Mg 2ϩ group (0.75% dietary Mg 2ϩ ), (3) aldosterone group (Aldo, 400 g/kg/min and 0.9% NaCl drinking water), and (4) AldoϩMg 2ϩ group. Blood pressure was unaltered by aldosterone and was similar in all groups throughout the experiment. Serum Na ϩ was increased and serum K ϩ and Mg 2ϩ decreased in the Aldo group. Aldo mice had hypomagnesuria and proteinuria, and renal, cardiac, and aortic fibrosis, which were normalized by Mg 2ϩ supplementation. Renal and cardiovascular expression of interleukin-6, VCAM1 and COX2 was increased in the Aldo group. Magnesium attenuated renal and cardiac interleukin-6 content and decreased renal VCAM1 and cardiac COX2 expression (PϽ0.05). Aldosterone decreased expression of renal TRPM7 and the downstream target annexin-1 (PϽ0.05) without effect on TRPM6. Whereas Mg 2ϩ increased mRNA expression of TRPM6 and TRPM7, it had no effect on TRPM7 and annexin-1 protein content. Our data demonstrate that aldosterone mediates blood pressure-independent renal and cardiovascular fibrosis and inflammation through Mg 2ϩ -sensitive pathways. We suggest that altered Mg 2ϩ metabolism in hyperaldosteronism may relate to TRPM7 downregulation and that Mg 2ϩ protects against cardiovascular and renal damaging actions of aldosterone. A ldosterone, classically thought to be produced by the zona glomerulosa of the adrenal cortex and implicated in the maintenance of sodium, potassium, and acid-base balance and blood pressure regulation, is now considered a hormone with pleiotropic actions, produced by multiple tissues, including the heart, vessels, kidney, and brain. 1,2 In addition to regulating renal electrolyte excretion, aldosterone contributes to vascular inflammation, oxidative stress, collagen deposition, and endothelial dysfunction. [3][4][5] As such, aldosterone has been implicated in the development of cardiovascular and renal remodeling, fibrosis, and injury. The importance of these processes in clinical medicine is being increasingly recognized by the cardiovascular and renal protective effects of the aldosterone antagonists, spironolactone and eplerenone. 6,7 The profibrotic and proinflammatory actions of aldosteronism are accompanied by disturbances in cation homeostasis including hypomagnesemia and decreased intracellular free magnesium concentration ([Mg 2ϩ ] i ). 8,9 Recent evidence suggests that aldosterone-induced cardiovascular inflammation is induced, in part...